TOSYMRA
Promius Pharma, LLC
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87815803 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Paul H. Kochanski |
| Attorney Docket Number | PROMIU.16 |
| Law Office Assigned | N50 |
| Employee Name | RADCLIFF, BRENT MARCUS |
Timeline
| 2018-03-01 | Application Filed |
| 2019-01-07 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-01-07 | Status: Live/Pending |
| 2019-01-08 | Transaction Date |
| 2019-02-12 | Published for Opposition |
Trademark Applicants & Owners
| Owner: |  Promius Pharma, LLC |
| Address | 107 College Road East Princeton DE 08540 |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical and medicinal preparations for the treatment of migraine |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2018-03-05 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-03-08 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-06-12 | 3 DOCK D:Assigned to Examiner |
| PRIORITY ACTION WRITTEN | 2018-06-15 | 4 CPRA R:Renewal |
| PRIORITY ACTION E-MAILED | 2018-06-15 | 5 GPRA F:First Action |
| NOTIFICATION OF PRIORITY ACTION E-MAILED | 2018-06-15 | 6 GPRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-12-14 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-12-14 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-12-14 | 9 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-12-16 | 10 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-01-23 | 11 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2019-02-12 | 12 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-02-12 | 13 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-04-09 | 14 NOAM E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-10-09 | 15 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-10-09 | 16 ARAA I:Incoming Correspondence |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2019-10-09 | 17 ASGN I:Incoming Correspondence |
| TEAS EXPRESS ABANDONMENT RECEIVED | 2019-10-16 | 18 EXAR I:Incoming Correspondence |
| ABANDONMENT - AFTER PUBLICATION | 2019-10-17 | 19 ABN5 O:Outgoing Correspondence |
| ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION | 2019-10-17 | 20 MAB5 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 TOSYMRA 88775112 not registered Live/Pending |
UPSHER-SMITH LABORATORIES, LLC 2020-01-27 |
 TOSYMRA 88390100 not registered Live/Pending |
UPSHER-SMITH LABORATORIES, LLC 2019-04-17 |
 TOSYMRA 87815803 not registered Live/Pending |
Promius Pharma, LLC 2018-03-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 